Cutaneous malignant melanoma in association with mycosis fungoides

Journal of the American Academy of Dermatology

Volumn 50, Issue 5, 2004, Pages 701-705

  Evans, Alun V ^a,b   Scarisbrick, Julia J ^a,b   Child, F J ^a,b   Acland, Katharine M ^a,b   Whittaker, Sean J ^a,b   Russell Jones, Robin ^a,b  

^a St John's Institute of Dermatology ^*

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CUTANEOUS T CELL LYMPHOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; MALE; MELANOMA; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND CANCER; UNITED KINGDOM;

EID: 2342503296     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.11.054     Document Type: Article

References (25)

1. Kantor AR, Curtis RE, Vonderheid EC, Van Scott EJ, Fraumeni JF Jr. Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 1989;63:1612-5.
2. Scarisbrick JJ, Child FJ, Evans AV, Fraser-Andrews EA, Spittle M, Russell-Jones R. Secondary malignant neoplasms in 71 patients with Sézary syndrome. Arch Dermatol 1999;135:1381-5.
3. Office for National Statistics. Cancer registration in England, 1998. London: Her Majesty's Stationary Office; 2001.
4. Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma: the influence of additional therapy after total skin electron beam radiation. Arch Dermatol 1995;131:432-5.
5. Reseghetti A, Tribbia G, Locati, Naldi L, Marchesi L. Cutaneous malignant melanoma appearing during photochemotherapy of mycosis fungoides. Dermatology 1994;189:75-7.
6. Soong V, Lee PC, Kissel RB, Sams WM Jr, Tyring SK. Fatal malignant melanoma associated with a completely regressed primary melanoma in a patient with cutaneous T-cell lymphoma [letter]. Arch Dermatol 1987;123:1270-2.
7. Stern RN. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001;44:755-61.
8. Amichai B, Grunwald MH, Goldstein J, Finkelstein E, Halevy S. Small malignant melanoma in patients with mycosis fungoides. J Eur Acad Dermatol Venereol 1998;11:155-7.
9. Riou JP, Ariyan S, Brandow KR, Fielding LP. The association between melanoma, lymphoma and other primary neoplasms. Arch Surg 1995;130:1056-61.
10. McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol 2000;143:171-3.
11. Travis LB, Curtis RE, Hankey BF, Fraumeni JF. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992;84:1422-7.
12. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukemias and skin cancers. Br J Cancer 1996;74:1847-50.
13. Tucker MA, Misfeldt D, Coleman CN, Clark WH Jr, Rosenberg SA. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 1985;102:37-41.
14. Spector BD, Filipovich AH. Nonlymphoid cancers as a complication of naturally occurring immunodeficiencies. In: Proceedings of the 71st annual meeting of the American Association for Cancer Research [abstract 603]. Baltimore: Waverly Press; 1980. p. 151.
15. Greene MH, Young TI, Clark WH. Malignant melanoma in renal transplant patients. Lancet 1981;1:1196-9.
16. Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, LeVee G, et al. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-, DR+ epidermal macrophage induction and Langerhans depletion. Proc Natl Acad Sci U S A 1992; 89:8497-501.
17. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000;2: 459-63.
18. Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin's lymphoma in Connecticut 1935-1988. Cancer 1992;70:840-9.
19. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, Glimelius B, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641-5.
20. Green MH, Petit-Frere C, Clingen PH, Bentham G, Cole J, Arlett CF. Possible effects of sunlight on human lymphocytes. J Epidemiol 1999;9(Suppl):S48-57.
21. Bentam G. Association between the incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996;312:1128-31.
22. McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L, et al. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 1999;112: 317-21.
23. MacKie RM. Risk factors for the development of primary cutaneous malignant melanoma. Dermatol Clin 2002;20:597-600.
24. Scarisbrick JJ, Woolford AJ, Calonje E, Photiou A, Ferreira S, Orchard G, et al. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sézary syndrome. J Invest Dermatol 2002;118:493-9.
25. Navas IC, Algara P, Mateo M, Martinez P, Garcia C, Rodriguez JL, et al. P16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides. Lab Invest 2002;82:123-32.